Prospective meta-analysis of randomised trials of cyclophosphamide, methotrexate & fluorouracil (CMF) vs fluorouracil, epirubicin & cyclophosphamide (FEC) chemotherapy in early breast cancer

被引：0
|
作者：
Marty, ME
Coombes, RC
Peckitt, C
López, FRP
Tres, A
Morvan, F
Tubiana-Mathieu, N
Espié, M
Bliss, JM
机构：
[1] Univ London Imperial Coll Sci Technol & Med, London, England
[2] Inst Gustave Roussy, Villejuif, France
[3] Univ London Imperial Coll Sci Technol & Med, CR UK Labs, London, England
[4] Canc Res Inst, Sutton, Surrey, England
[5] Hosp Clin Zaragoza, Zaragoza, Spain
[6] Ctr Hosp Rene Dubos, Pontoise, France
[7] Hop Dupuytren, Limoges, France
[8] Hop St Louis, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
592
引用
收藏
页码：25S / 25S
页数：1
相关论文
共 50 条
  • [31] LOW-DOSE CHEMOTHERAPY OF METASTATIC BREAST-CANCER WITH CYCLOPHOSPHAMIDE, ADRIAMYCIN, METHOTREXATE, 5-FLUOROURACIL (CAMF) VERSUS SEQUENTIAL CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL (CMF) AND ADRIAMYCIN
    CREECH, RH
    CATALANO, RB
    HARRIS, DT
    ENGSTROM, PF
    GROTZINGER, PJ
    CANCER, 1979, 43 (01) : 51 - 59
  • [32] COMBINATION CHEMOTHERAPY WITH CMF (CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL) VERSUS CNF (MITOXANTRONE, 5-FLUOROURACIL, CYCLOPHOSPHAMIDE) IN ADVANCED BREAST-CANCER - A MULTICENTER RANDOMIZED STUDY
    LORUSSO, V
    VICI, P
    BIANCO, AR
    LOPEZ, M
    DEPLACIDO, S
    PIANO, A
    PALOMBA, G
    CARLOMAGNO, C
    DAPRILE, M
    FOSSER, V
    BRANDI, M
    DELENA, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1993, 2 (04) : 531 - 535
  • [33] Adjuvant fluorouracil, epirubicin and cyclophosphamide in early breast cancer: Is it cost-effective?
    Norum, J
    Holtmon, M
    ACTA ONCOLOGICA, 2005, 44 (07) : 735 - 741
  • [34] Hepatic toxicity during adjuvant cyclophosphamide, methotrexate and 5-Fluorouracil (CMF) in breast cancer
    Noberasco, C
    Peruzzotti, G
    Colleoni, M
    Nole, F
    deBraud, F
    Martinelli, G
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 1998, 9 : 7 - 7
  • [35] Feasibility and toxicity of docetaxel before or after fluorouracil, epirubicin and cyclophosphamide as adjuvant chemotherapy for early breast cancer
    Abe, Hajime
    Mori, Tsuyoshi
    Kawai, Yuki
    Cho, Hirotomi
    Kubota, Yoshihiro
    Umeda, Tomoko
    Kurumi, Yoshimasa
    Tani, Tohru
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (03) : 487 - 491
  • [36] Feasibility and toxicity of docetaxel before or after fluorouracil, epirubicin and cyclophosphamide as adjuvant chemotherapy for early breast cancer
    Hajime Abe
    Tsuyoshi Mori
    Yuki Kawai
    Hirotomi Cho
    Yoshihiro Kubota
    Tomoko Umeda
    Yoshimasa Kurumi
    Tohru Tani
    International Journal of Clinical Oncology, 2013, 18 : 487 - 491
  • [37] COMBINATION CHEMOTHERAPY FOR METASTATIC BREAST-CANCER WITH FLUOROURACIL, ADRIAMYCIN, CYCLOPHOSPHAMIDE, AND METHOTREXATE
    ABOUD, A
    BUZDAR, AU
    YAP, HY
    HORTOBAGYI, GN
    BLUMENSCHEIN, GR
    JOURNAL OF SURGICAL ONCOLOGY, 1984, 26 (03) : 205 - 207
  • [38] CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL FOR BREAST-CANCER
    HOWELL, A
    GEORGE, WD
    CROWTHER, D
    RUBENS, RD
    BULBROOK, RD
    BUSH, H
    HOWAT, JMT
    SELLWOOD, RA
    HAYWARD, JL
    FENTIMAN, IS
    CHAUDARY, M
    LANCET, 1984, 2 (8398): : 307 - 311
  • [39] Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients with Primary Breast Cancer
    Iwata, Hiroji
    Sato, Nobuaki
    Masuda, Norikazu
    Nakamura, Seigo
    Yamamoto, Naohito
    Kuroi, Katsumasa
    Kurosumi, Masafumi
    Tsuda, Hitoshi
    Akiyama, Futoshi
    Ohashi, Yasuo
    Toi, Masakazu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (07) : 867 - 875
  • [40] Prospective randomized study of cyclophosphamide, epirubicin, and 5-fluorouracil versus cyclophosphamide, adriamycin, and 5-fluorouracil in advanced or recurrent breast cancer
    Kobayashi T.
    Koyama H.
    Oka T.
    Yasumura T.
    Kan N.
    Takatsuka Y.
    Noguchi M.
    Morimoto K.
    Suzuki T.
    Tobe T.
    Mori T.
    Breast Cancer, 1999, 6 (1) : 37 - 42
12345